Chronic Kidney Disease Is Now a Global Silent Killer — Why Isn’t Anyone Talking About It?

慢性肾病已成为全球隐形杀手，为何没人讨论？

timesofindia.indiatimes.com

So chronic kidney disease now ranks as the ninth leading cause of death worldwide — ahead of diabetes and many cancers — and yet less than 10% of affected people even know they have it. Let that sink in. It’s not some rare tropical disease; we’re talking 800 million people, mostly in wealthy or middle-income nations, quietly heading toward organ failure.

慢性肾病如今已位居全球第九大死因，排在糖尿病和多种癌症之前，但不足10%的患者知道自己患病。想想看吧。这可不是什么罕见的热带病，我们说的是8亿人，大多数生活在中高收入国家，却正悄无声息地走向器官衰竭。

The worst part? The tools to catch it early—urine tests, blood pressure checks, and glucose monitoring—are dirt cheap and widely available. It’s not about tech or access. It’s about awareness. We’re failing our own people by not pushing routine kidney screening like we do mammograms or colonoscopies.

最糟糕的是？早期发现的工具——尿检、血压检查和血糖监测——成本极低且广泛可用。问题不在于技术或可及性，而在于认知。我们并未像推广乳腺X光或结肠镜一样推动常规肾脏筛查，这是对民众的失职。

Nephro Doc on Call (值班肾病医生)

As a nephrologist, I see this every day. Patients come in with stage 4 CKD and say, 'But I felt fine!' The kidneys are silent workhorses — they don’t scream until 90% are gone. That’s why urine albumin and eGFR tests should be in every annual checkup. Not 'if at risk' — for everyone.

作为一名肾病科医生，我每天都在面对这种情况。患者带着四期慢性肾病来看诊，却说‘可我一直感觉很好啊！’ 肾脏是沉默的劳模，功能只剩10%时才会‘叫喊’。这就是为何尿白蛋白和eGFR检测应纳入每年常规体检，不是‘高危人群才做’，而是每个人都该做。

Diabetic Since 15 (15岁起患糖尿病者)

I’ve been getting kidney tests every 6 months since I was 16. It’s the one thing diabetes education actually drilled into us. But when I talk to friends without diabetes, they think kidney tests are only for old people or drug users. Massive awareness gap.

从16岁起，我就每半年做一次肾功能检查。这是糖尿病教育中唯一真正深入我们脑海的一点。但当我跟没有糖尿病的朋友聊天时，他们却以为肾检只是老年人或吸毒者才需要。认知鸿沟巨大。

Med School Realist (现实主义医学生)

Universal screening sounds great in theory, but what about cost-effectiveness? We screen millions for early CKD, most of whom will never progress to kidney failure. Is that the best use of limited healthcare funds?

普遍筛查理论上听上去不错，但成本效益如何？我们为数百万人做早期肾病筛查，其中大多数人永远不会发展成肾衰竭。这真的是有限医疗资金的最佳用途吗？

Econ PhD in Health Policy (健康政策方向经济学博士)

Actually, modeling shows early detection prevents dialysis down the line — and dialysis costs 10x more per patient per year than screening. Preventive care pays for itself. We just don’t see the savings because they’re spread across decades.

实际上，模型显示早期发现能避免后期透析——而每位患者的年度透析费用是筛查的10倍。预防性医疗能自给自足，只是我们看不到节省的钱，因为效益分布在几十年间。

Skeptical Policy Analyst (怀疑派政策分析师)

Okay, but implementation is the real killer. In the US, even if screening is cheap, patients avoid doctors unless they’re in pain. Until we fix access and trust, awareness campaigns are just posters on a clinic wall.

好吧，但实施才是真正的难题。在美国，即使筛查很便宜，除非感到疼痛，患者也不会去看医生。除非改善就医可及性和信任感，否则宣传运动不过是诊所墙上的一张海报。

Data Junkie (数据控)

The Lancet data shows CKD prevalence rose faster in South Asia and Sub-Saharan Africa than anywhere else. Yet those regions have the fewest nephrologists and dialysis centers. This isn’t just a health issue — it’s a global inequality bomb ticking quietly.

《柳叶刀》数据显示，南亚和撒哈拉以南非洲的肾病患病率增速超过全球其他地区。但这些地区肾病医生和透析中心却最少。这已不只是健康问题，而是正在悄然倒计时的全球不平等炸弹。

Granny With Glucose Monitor (戴着血糖仪的老奶奶)

My doctor made me pee in a cup at every visit. I thought it was overkill. Then my cousin died on dialysis. Now I do it without question. These tests are not ‘extra’ — they’re armor.

每次复诊，医生都让我留尿。我以为是小题大做。后来表亲在透析中去世。现在我毫无怨言地做检查。这些检测不是‘多余’的，而是盔甲。

Public Health Wonk (公共卫生狂热者)

Exactly. We treat prevention like an option. But when the bill comes due, we pay 100x more — in money and lives.

没错。我们把预防当作可选项。但当账单到期时，我们却要付出百倍的金钱和生命代价。

Chronic Kidney Disease Is Now a Global Silent Killer — Why Isn’t Anyone Talking About It?

慢性肾病已成为全球隐形杀手，为何没人讨论？

城市正在扼杀我们的健康——这份世卫指南真能拯救都市人吗？

医生说走路就是治疗膝关节炎的新止痛药——可我们为啥还坐着不动？